Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 10/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | LIPE | Q05469 | 2/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17334100 | 0.85 | LPL (0.42) | LPLLIPGLIPEP4HB | |
| SCHEMBL31138592 | 0.85 | LPL (0.42) | LPLLIPGALDH1A1TSHRTDP1 | |
| SCHEMBL23526251 | 0.85 | LPL (0.42) | LPLLIPGCA2LIPEP4HB | |
| SCHEMBL5899734 | 0.83 | LPL (0.54) | LPLLIPGCA2P4HBANPEP | |
| SCHEMBL20940140 | 0.82 | LPL (0.43) | LPLLIPGLIPEP4HBANPEP | |
| SCHEMBL29382961 | 0.82 | LPL (0.43) | LPLLIPGALDH1A1TDP1LIPE | |
| SCHEMBL23332740 | 0.82 | LPL (0.43) | LPLLIPGLIPEP4HBANPEP | |
| SCHEMBL9755 | 0.82 | LPL (0.43) | LPLLIPGALDH1A1TDP1LIPE | |
| SCHEMBL29470921 | 0.82 | LPL (0.36) | LPLLIPGALDH1A1TSHRTDP1 | |
| SCHEMBL24171841 | 0.80 | LPL (0.39) | LPLLIPGALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3739641-B1 | N-TYPE SEMICONDUCTOR COMPOSITION, AND THIN FILM, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-08-13 | — | — | EP | disclosed |
| US-11322688-B2 | N-type semiconductor composition, and thin film, organic photoelectric device, image sensor, and electronic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-05-03 | — | — | US | disclosed |
| US-20200365807-A1 | N-TYPE SEMICONDUCTOR COMPOSITION, AND THIN FILM, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| EP-3739641-A1 | N-TYPE SEMICONDUCTOR COMPOSITION, AND THIN FILM, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2020-11-18 | — | — | EP | disclosed |
| CN-111952452-A | N-type semiconductor composition, and film, organic photoelectric device, image sensor and electronic device comprising same | 三星电子株式会社 | 2020-11-17 | — | — | CN | disclosed |
| US-10004701-B2 | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (US) | 2018-06-26 | — | — | US | disclosed |
| US-10004701-B2 | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (US) | 2018-06-26 | — | — | US | disclosed |
| US-10004701-B2 | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (US) | 2018-06-26 | — | — | US | disclosed |
| US-20170065540-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | UNIVERSITY OF ROCHESTER (US) | 2017-03-09 | — | — | US | disclosed |
| US-20170065540-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | UNIVERSITY OF ROCHESTER (US) | 2017-03-09 | — | — | US | disclosed |
| US-20170065540-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | UNIVERSITY OF ROCHESTER (US) | 2017-03-09 | — | — | US | disclosed |
| US-20150238473-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-27 | — | — | US | disclosed |
| US-20150238473-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-27 | — | — | US | disclosed |
| US-20150238473-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238473-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | MMP8, IFNG, MPO | LPL 503/4885LIPG 1015/4885ALDH1A1 2568/4885 |
| US-20200365807-A1 | N-TYPE SEMICONDUCTOR COMPOSITION, AND THIN FILM, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | NCS1, SCN1A, EFNA1 | LPL 4266/4885LIPG 3115/4885ALDH1A1 4171/4885 |
| US-11322688-B2 | N-type semiconductor composition, and thin film, organic photoelectric device, image sensor, and electronic device including the same | NCS1, SCN1A, EFNA1 | LPL 4266/4885LIPG 3115/4885ALDH1A1 4171/4885 |
| US-20170065540-A1 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | MMP8, IFNG, MPO | LPL 503/4885LIPG 1015/4885ALDH1A1 2568/4885 |
| US-10004701-B2 | Methods and compositions for treating infection | MMP8, IFNG, MPO | LPL 503/4885LIPG 1015/4885ALDH1A1 2568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.